Publicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (10)

2022

  1. Angiocrine polyamine production regulates adiposity

    Nature Metabolism, Vol. 4, Núm. 3, pp. 327-343

  2. Kappa-Opioid Receptor Blockade Ameliorates Obesity Caused by Estrogen Withdrawal via Promotion of Energy Expenditure through mTOR Pathway

    International Journal of Molecular Sciences, Vol. 23, Núm. 6

  3. Prolonged breastfeeding protects from obesity by hypothalamic action of hepatic FGF21

    Nature Metabolism, Vol. 4, Núm. 7, pp. 901-917

2021

  1. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

    British Journal of Pharmacology, Vol. 178, Núm. 10, pp. 2131-2145

2020

  1. Oral Pharmacological Activation of Hypothalamic Guanylate Cyclase 2C Receptor Stimulates Brown Fat Thermogenesis to Reduce Body Weight

    Neuroendocrinology, Vol. 110, Núm. 11-12, pp. 1042-1053

2019

  1. Uroguanylin improves leptin responsiveness in diet-induced obese mice

    Nutrients, Vol. 11, Núm. 4

2018

  1. SIRT1 mediates obesity- and nutrient-dependent perturbation of pubertal timing by epigenetically controlling Kiss1 expression

    Nature Communications, Vol. 9, Núm. 1

  2. Sex-Biased Physiological Roles of NPFF1R, the Canonical Receptor of RFRP-3, in Food Intake and Metabolic Homeostasis Revealed by its Congenital Ablation in mice

    Metabolism: Clinical and Experimental, Vol. 87, pp. 87-97

2016

  1. Antiobesity efficacy of GLP-1 receptor agonist liraglutide is associated with peripheral tissue-specific modulation of lipid metabolic regulators

    BioFactors, Vol. 42, Núm. 6, pp. 600-611

  2. EndoG knockout mice show increased Brown adipocyte recruitment in white adipose tissue and improved glucose homeostasis

    Endocrinology, Vol. 157, Núm. 10, pp. 3873-3887